In Episode 12 of PancChat, host Alisyn Camerota speaks with Diana Jupp, CEO of Pancreatic Cancer UK, about global advocacy, differences between UK and US approaches, and the power of collaboration through the World Pancreatic Cancer Coalition.

Learn how awareness campaigns, patient voices, and international partnerships are helping drive progress in pancreatic cancer research, diagnosis, and care.

Thank you to our sponsor, Revolution Medicines.

For more information and support, visit letswinpc.org and pancan.org.

Resources:

letswinpc.org
pancan.org

In this episode of PancChat, host Alisyn Camerota speaks with Kerry McKean Kelly, founder of Kelly's Heroes, about the power of collaboration in pancreatic cancer advocacy.

Kerry shares her personal journey after losing her husband Steve to stage IV pancreatic cancer and how she channeled her grief into global advocacy work. As outgoing chair of the World Pancreatic Cancer (WPCC) Day Committee, Kerry discusses the importance of clinical trial awareness, how the World Pancreatic Cancer Coalition unites 100+ organizations worldwide, why patient empowerment matters across all healthcare systems, and the progress being made in pancreatic cancer survival rates.

"We are stronger together than we are alone." - Kerry McKean Kelly

Resources mentioned:

- Kelly's Heroes: http://www.kellysheroes.ngo/

- World Pancreatic Cancer Coalition: www.hellopancreas.com

- PanCAN: www.pancan.org

- Let's Win: www.letswinpc.org

Thank you to our sponsor, Revolution Medicines.

For more information and support, visit letswinpc.org and pancan.org.

Join host Alisyn Camerota as she welcomes Dr. Asaf Maoz from Dana-Farber Cancer Institute to explore the science behind genetic mutations in pancreatic cancer. Building on Episode 9's discussion of the genetic testing journey, this episode dives into hereditary risk and the specific types of mutations patients and families may encounter.

Dr. Maoz, an attending physician in the Division of Genetics and Prevention and faculty member at Harvard Medical School, explains why genetic testing is now the standard of care, identifies the most common hereditary mutations linked to pancreatic cancer, and discusses what results mean for patients and their families — including when no actionable mutations are found. Learn about the critical role of family history in understanding pancreatic cancer risk.